Congenital tuberculosis
ICD-10 P37.0 is a billable code used to indicate a diagnosis of congenital tuberculosis.
Congenital tuberculosis is a rare but serious condition that occurs when Mycobacterium tuberculosis is transmitted from an infected mother to her fetus during pregnancy. This transmission can occur through hematogenous spread or, less commonly, through the placenta. Newborns with congenital tuberculosis may present with a variety of symptoms, including respiratory distress, failure to thrive, and signs of systemic infection. Diagnosis is often challenging due to the nonspecific nature of symptoms and the need for specialized testing, such as PCR for Mycobacterium tuberculosis or culture from respiratory secretions. Early identification and treatment are crucial to prevent severe morbidity and mortality. Treatment typically involves a combination of antitubercular medications, and close monitoring in a neonatal intensive care unit (NICU) is often required. The management of congenital tuberculosis also necessitates a multidisciplinary approach, involving neonatologists, infectious disease specialists, and pediatricians to ensure comprehensive care for the affected newborn.
Detailed documentation of clinical findings, diagnostic tests, and treatment plans is essential. Neonatologists must ensure that all relevant maternal history is included.
A newborn presenting with respiratory distress and fever in the NICU, with a mother who has a history of tuberculosis.
Neonatologists should be aware of the potential for rapid deterioration in affected infants and the need for immediate intervention.
Pediatricians must document ongoing assessments of growth and development, as well as any complications arising from congenital tuberculosis.
A pediatric follow-up visit for a child diagnosed with congenital tuberculosis, monitoring for long-term effects.
Pediatricians should consider the psychosocial aspects of managing a child with a congenital infection and involve family support services.
Used for screening in newborns with suspected congenital tuberculosis.
Document the indication for the test and results.
Neonatologists should be aware of the limitations of skin testing in infants.
Key symptoms include respiratory distress, fever, lethargy, and failure to thrive. Early identification is crucial for effective management.
